Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.
Nom du journal : Ann Oncol
Année : 2023
Volume : 34
Page de départ : 772-782
